Chun Kyon Lee

Chun Kyon Lee

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2011 in Journal of Viral Hepatitis
Verified
Journal Article
Closed access
PDF file
MKM. S. Kwak
M. S. Kwak
JCJ. W. Choi
J. W. Choi
JLJ. S. Lee
J. S. Lee
KKK. A. Kim
K. A. Kim
JSJ. H. Suh
J. H. Suh
CLChun Kyon Lee
Chun Kyon Lee

29 April 2013 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
YJYoung-Joo Jin
Young-Joo Jin
JLJin-Woo Lee
Jin-Woo Lee
JLJung Il Lee
Jung Il Lee
SPSang-Hoon Park
Sang-Hoon Park
CPChoong Kee Park
Choong Kee Park
SHSeungbong Han
Seungbong Han
Two recent Italian studies suggested that Pegylated-interferon (PEG-IFN) alfa-2a achieves a higher sustained virological response (SVR) rate than PEG-IFN alfa-2b. We intended to compare the efficacy and safety of PEG-IFN alfa-2a with those of PEG-IFN alfa-2b in Korean patients with chronic hepatitis C virus (HCV). This retrospective, multi-center trial was conducted on 661 treatment-naïve chronic HCV patients. Patients received PEG-IFN alfa-2a (180 μg/week; n=402) or PEG-IFN alfa-2b (1.5 μg/kg/week; n=259) with ribavirin (800–1200 mg/day) for 24 or 48 weeks according to HCV genotypes. Early virologic response and sustained virologic response (SVR) rates were not significantly different between two PEG-IFN groups both in patients with HCV genotype 1 (all P-values>0.05) and 2/3 (all P-values>0.05). SVR rates were not different between two groups in each categorized baseline characteristics: age (years) (≤50 and >50), HCV viral load (IU/mL) (≤7×105 and >7×105), and hepatic fibrosis (F0-2 and F3-4) (all P-values >0.05). In additional analysis for 480 patients who sufficiently complied with treatment doses and duration (80/80/80 rule) and propensity-score matched analysis, SVR rates were not different between two groups both in patients with HCV genotype 1 and 2/3 (all P-values >0.05). Adverse event rates were similar between two groups. Unlike the Western data, efficacy and safety of PEG-IFN alfa-2a were similar to those of PEG-IFN alfa-2b in chronically HCV-infected Korean patients regardless of age, HCV viral load, and hepatic fibrosis.

16 January 2007 in Liver International
Verified
Journal Article
Closed access
PDF file
DKDo Young Kim
Do Young Kim
HKHong Jeoung Kim
Hong Jeoung Kim
CLChun Kyon Lee
Chun Kyon Lee
JSJeong Hun Suh
Jeong Hun Suh
DKDong Hwan Kim
Dong Hwan Kim
IPIn Suh Park
In Suh Park

1 December 2002
Verified
Journal Article
Closed access
CLChun Kyon Lee
Chun Kyon Lee
JSJeong Hun Suh
Jeong Hun Suh
YCYoung Suk Cho
Young Suk Cho
KHKwang-Hyub Han
Kwang-Hyub Han
JCJae Bock Chung
Jae Bock Chung
YMYoung Myoung Moon
Young Myoung Moon

1 January 2018 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
JCJong Won Choi
Jong Won Choi
SKSe Hyun Kim
Se Hyun Kim
JSJeong Hun Seo
Jeong Hun Seo
YCYong Suk Cho
Yong Suk Cho
SWSun Young Won
Sun Young Won
CLChun Kyon Lee
Chun Kyon Lee
Choi JW, et al. Yonsei Med J. 2018 May;59(3):383-388. https://doi.org/10.3349/ymj.2018.59.3.383

10 March 2022 in The Korean Journal of Helicobacter and Upper Gastrointestinal Research
Verified
Journal Article
Open access
PDF file
ECEun Ju Choe
Eun Ju Choe
HJHan Ho Jeon
Han Ho Jeon
YCYong Suk Cho
Yong Suk Cho
SWSun Young Won
Sun Young Won
JSJeong Hun Seo
Jeong Hun Seo
YLYong Kang Lee
Yong Kang Lee
Background/Aims: This study aimed to compare the efficacy of a recently developed clear-cut knife with that of widely used knives for endoscopic submucosal dissection (ESD) in early gastric cancer (EGC).Materials and Methods: Data were collected retrospectively from the National Health Insurance Service Ilsan Hospital between May 2017 and April 2019. The study included 105 patients (108 lesions) with EGC who underwent ESD. Fifty-six EGCs were dissected using an insulation-tipped diathermic knife in combination with a needle knife, while 52 EGCs were dissected using a clear-cut knife, a single device with an integrated needle and an insulated-tipped knife. Oncologic outcomes and technical success were compared between the two groups.Results: The distribution of the tumor locations, composition of the undifferentiated types of EGCs, and the size of EGCs (14.3±8.0 vs. 16.6±7.3 mm; P=0.130) were not significantly different between the groups. The complete (98.2% vs. 94.2%; P=0.273) and curative (87.5% vs. 88.5%; P=0.878) resection rates were not statistically different. Furthermore, no significant difference between the total procedure times (39±34.1 vs. 35.7±20.1 minutes; P=0.554), areas of the dissected specimen (858.6±406.5 vs. 980.3±393.8 mm2; P=0.119) and dissected areas per minute (32.4±17.9 vs. 35.5±16.2 mm2/min; P=0.345) were noted. Regarding complications, the overall perforation rates (3.6% vs. 4.0%) and bleeding rates (3.6% vs. 8.0%) were not statistically different.Conclusions: The newly developed clear-cut knife is as useful as the combination of classical knives for ESD in EGC.